Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis
Go back to Organon’s VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis| (NYSE: OGN) | Delayed: 13.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.43 | 52 Week High | $8.00 | |||
| Open | $13.43 | 52 Week Low | $8.00 | |||
| Day High | $13.43 | P/E | N/A | |||
| Day Low | $13.43 | EPS | $0.00 | |||
| Volume | 1,481 | |||||
